48
Participants
Start Date
November 22, 2024
Primary Completion Date
December 18, 2024
Study Completion Date
March 14, 2025
Iron Sucrose injection (Test product, manufactured by Sichuan Huiyu Pharmaceutical Co., Ltd) and Iron Sucrose injection (Reference product, Venofer)
For the Group I, participants will receive a single intravenous injection of the Test Product (Iron sucrose injection, 100 mg iron/5 mL, manufactured by Sichuan Huiyu Pharmaceutical Co., Ltd). After a washout period, subjects will receive a single intravenous injection of the Reference Product (Iron sucrose injection, Venofer®, 100 mg iron/5 mL, held by Vifor France).
Iron Sucrose injection (Reference product, Venofer) and Iron Sucrose injection (Test product, manufactured by Sichuan Huiyu Pharmaceutical Co., Ltd)
For the Group II, participants will receive a single intravenous injection of the Reference Product (Iron sucrose injection, Venofer®, 100 mg iron/5 mL, held by Vifor France) . After a washout period, subjects will receive a single intravenous injection of the Test Product (Iron sucrose injection, 100 mg iron/5 mL, manufactured by Sichuan Huiyu Pharmaceutical Co., Ltd).
Henan (Zhengzhou) Zhonghui Cardiovascular Hospital, Zhengzhou
Collaborators (1)
Henan (Zhengzhou) Zhonghui Cardiovascular Hospital
UNKNOWN
Changsha Duxact Biotechnology Co., Ltd
UNKNOWN
Suzhou Guochen Biotechnology Co., Ltd.
UNKNOWN
Sichuan Huiyu Pharmaceutical Co., Ltd
INDUSTRY